If you are considering taking part in a clinical trial at ALYATEC, you will find below the list of ongoing studies:

 

Study TT-07: birch pollen rhinitis

Who is eligible? Adolescents aged 12 to 17 having symptoms of allergic rhinitis  to birch pollen.

What is the purpose of the study? To evaluate the efficacy of a desensitization treatment.

When? Inclusion of participants from October 2026.

What else? Compensation of 1100€ for four visits to be carried out at ALYATEC.

 

>> More information <<

 

Study ALY-ALK001: birch pollen rhinitis

Who is eligible? Adolescents aged 12 to 17 having symptoms of allergic rhinitis or rhinoconjunctivitis to birch pollen.

What is the purpose of the study? To identify the allergic profile of adolescent patients allergic to birch pollen.

When? Inclusion of participants from 20th April 2026.

What else? Compensation of 50€ for two visits (30 minutes + 1 hour) to be carried out at ALYATEC.

 

>> More information <<

Upcoming clinical studies

Additional clinical studies will be starting soon at ALYATEC, particularly in the areas of atopic dermatitis (eczema) and food allergies (peanuts, hazelnuts, walnuts, sesame, fish, soy, egg, wheat, etc.).

Please feel free to contact us to schedule an appointment and register in our volunteer database.

You may also refer friends or family members to participate in a study and earn €50 through our referral program.